Price Alert

Dermata Therapeutics Inc. (DRMA)

NASDAQ: DRMA · Real-Time Price · USD

5.90

0.09 (1.55%)

At close: Aug 15, 2025, 3:59 PM

5.98

1.36%

After-hours: Aug 15, 2025, 04:00 PM EDT

Dermata Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	6.48M	9.72M	3.16M	6.14M	4.95M	4.73M	7.44M	6.63M	8.44M	8.77M	6.24M	8.07M	10.63M	8.19M	10.8M	12.6M	427.2K	1.33M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	540.5M	n/a	n/a	n/a	703.19M	n/a	n/a	200K	825.13M	n/a	677.8K	265.35K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	8.36K	n/a	n/a	6.36K	12.6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	75.51K	n/a	n/a	144.29K	92.9K	n/a	76.29K	67.5K	80.87K	n/a	n/a	n/a	179.59K	55.72K	n/a	687.33K	278.07K
Total Current Assets	6.48M	10.01M	3.53M	6.69M	5.24M	5.18M	7.98M	7.32M	8.71M	9.3M	6.94M	8.97M	11.03M	9.04M	11.62M	13.69M	1.14M	1.65M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	540.5M	n/a	n/a	n/a	703.19M	n/a	n/a	200K	825.13M	n/a	677.8K	265.35K
Total Assets	6.64M	10.01M	3.53M	6.69M	5.24M	5.18M	7.98M	7.32M	8.71M	9.3M	6.94M	8.97M	11.03M	9.04M	11.62M	13.69M	1.14M	1.65M
Account Payables	413.69K	1.4M	808.01K	863.6K	1.33M	822.55K	866.03K	474.46K	437.78K	492.87K	496.7K	483.74K	608.81K	662.23K	515.25K	769.86K	881.31K	488.09K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174.84K	174.77K
Other Current Liabilities	413.69K	961.76K	731.63K	327.24K	n/a	n/a	n/a	n/a	n/a	131.26K	n/a	n/a	n/a	n/a	0.00	0.00	n/a	n/a
Total Current Liabilities	413.69K	2.7M	1.97M	1.95M	1.92M	1.37M	1.62M	916.82K	682.86K	1.21M	922.63K	1.5M	1.37M	1.19M	1.52M	1.2M	1.64M	939.18K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	612.58K	1.31M	1.16B	1.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	612.58K	1.31M	1.16B	1.08M	n/a	n/a	757.59M	442.36K	245.08K	n/a	496.7K	1.02M	757.66K	662.23K	515.25K	n/a	n/a	n/a
Total Liabilities	1.03M	2.7M	1.97M	1.95M	1.92M	1.37M	1.62M	916.82K	682.86K	1.21M	922.63K	1.5M	1.37M	1.19M	1.52M	1.2M	1.64M	939.18K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174.84K	174.77K
Common Stock	64.00	603.00	252.00	168.00	69.00	666.00	393.00	319.00	319.00	239.00	1.23K	1.21K	1.01K	833.00	833.00	833.00	191.00	191.00
Retained Earnings	-69.68M	-67.98M	-65.68M	-62.52M	-59.35M	-56.52M	-53.39M	-51.25M	-49.53M	-47.83M	-45.59M	-43.92M	-41.5M	-38.77M	-35.98M	-33.43M	-31.72M	-30.38M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	0.00	n/a
Shareholders Equity	5.61M	7.3M	1.56M	4.74M	3.32M	3.81M	6.36M	6.41M	8.03M	8.09M	6.02M	7.47M	9.66M	7.85M	10.11M	45.92M	-505.8K	712K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a